On August 3, 2017, Bristol-Myers Squibb (BMS) announced that it has agreed to acquire biotech firm, IFM Therapeutics, in a deal worth over $1 billion to develop BMS’ oncology pipeline. / read more /
Following passage by the House in July 2017, the Senate has voted to pass a reauthorization bill for FDA user-fee programs for drugs and medical devices ahead of the user-fee programs’ expiration date. / read more /
advertisement
YOUR OPINION MATTERS
Tell us what you think of Pharmaceutical Technology Europe by taking part in our readers survey.
The goal of the new facility features instrumentation, software, and systems designed to facilitate the use of QbD for drug substances and intermediates development. / read more /
Through its life-sciences business, MilliporeSigma, Merck KGaA will collaborate with Baylor College of Medicine to advance vaccine development for neglected and emerging diseases. / read more /
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline. / read more /
Charles River Labs has announced the acquisition of Brains On-Line (US), a contract research organization (CRO) that provides data on therapeutics for treating central nervous system (CNS) diseases. / read more /
Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel. / read more /
CPhI survey seeks industry input to rank top-performing nations on pharma manufacturing and business factors.
CPhI Worldwide, a sister company to Pharmaceutical Technology, is conducting a global ranking of the top 10 pharmaceutical countries to assess reputations in API production, finished dosage formulations, growth potential, innovation, regulatory acumen, and other factors.
The survey invites participants to share opinions about the performance and reputations of the United Kingdom, France, Italy, Germany, India, the United States, Japan, China, Korea, and Spain. The survey also measures market competitiveness, business growth, transparency, and pharma knowledge.
The insights provided from the survey will build a global picture of the state and strength of the international pharma industry, the survey sponsors report. Individual responses to the survey are anonymous. A summary of the compiled results will be available on www.PharmTech.com. Complete results will be published on the CPhI Pharma Insights webpage. / Pharma industry professionals are invited to take the 12-minute survey via this link. /
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities. / read more /
Broad Technology Toolkit to Accelerate Drug Development
Catalent has the broadest range of technologies and solutions to overcome developmental and bioavailability challenges, and to enhance product performance. / Read more/
Cleanroom Documentation
VAI has solved the challenges surrounding particulate and fiber contamination in controlled areas by developing CleanPrint 10, the Core2Print, and Core2Write and has addressed cleanroom traceability via our Core2Scan System. / Read more/
Date: 24-26 October 2017 Venue: Messe Frankfurt, Germany
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. The exhibition covers every sector of the pharmaceutical market under one roof. / Read more/
A three-volume set of drug delivery system handbooks. A compilation of articles related to methods and processes of manufacturing and administering pharmaceutical compounds to achieve therapeutic effects. Topics include the development of controlled-release formulations and reformulating injectable drugs for oral delivery. / Click here /
New technologies, including single-use systems, are leading the push for faster production and higher titers. At the same time, ensuring quality in raw materials and water systems, and controlling contamination are paramount. In this Biologics and Sterile Manufacturing eBook, the editors explore key technology, process, and operational topics.
